NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy
NCT04999046
Brain Diseases, Central Nervous System Diseases
Taipei, Taiwan
View Trial DetailsNCT Number: NCT01694524
Few studies dealing with the risk of infectious of nervous system and the utility of lumbar puncture and of emergent neuroimaging among patients with simple febrile seizure between 3 and 11 months age and with complex seizure has been reported. None of these studies was multicentric. Recommendations about management of these children are heterogeneous.
The investigators aim to study by an observational retrospective multicentric study the rate of infectious of central nervous system among patients with a complex febrile seizure and among patients between 3 and 11 months age with simple febrile seizure.
Looking for future studies?
Notify Me3 month–5 year
All sexes
Observational
Hopital Jean Verdier, Bondy, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 7 days after emergency visit
Results of lumbar puncture or meningitis history in charts
Time frame: 7 days after emergency visit
Results of lumbar puncture or meningitis history in charts
Time frame: 7 days after emergency visit
Hôpital Armand Trousseau
Other
Nervous System Infections Among Patients With Febrile Seizure : Retrospective Cohort Review of Consecutive Patients Admitted in 7 Pediatric Emergency Departments in Ile-de-France Between 2007 and 2011
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04999046
Brain Diseases, Central Nervous System Diseases
Taipei, Taiwan
View Trial DetailsNCT07508670
Brain Diseases, Brain Ischemia
Cork, Ireland
View Trial DetailsNCT06741930
Brain Diseases, Central Nervous System Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06703983
Brain Diseases, Central Nervous System Diseases
Mashhad, Razavi Khorasan Province, Iran
View Trial Details